These findings indicate that RJEVs facilitate diabetic wound healing through the coordinated regulation of fibroblast function, immune modulation, and angiogenesis. This study introduces a nature-derived, non-mammalian extracellular vesicle platform with translational potential for chronic wound management in diabetes, offering a biocompatible and multifaceted therapeutic alternative to conventional approaches.